Xymoheal Forte Tablet contains Trypsin Chymotrypsin (200000 AU), a potent proteolytic enzyme combination used primarily for its anti-inflammatory, anti-edematous, and fibrinolytic properties. This formulation is indicated for the management of acute and chronic inflammatory conditions, including post-operative swelling, trauma, and soft tissue injuries. By facilitating the breakdown of proteinaceous debris and inflammatory mediators at the site of injury, Trypsin Chymotrypsin promotes faster resolution of inflammation and enhances tissue repair. The enzymatic action also aids in reducing edema and pain, thereby improving patient mobility and comfort. Xymoheal Forte is commonly prescribed as an adjunct therapy in musculoskeletal disorders, including sprains, strains, and tendonitis, as well as in post-surgical recovery to minimize swelling and promote wound healing. The recommended dosage should be adhered to as per medical advice to optimize therapeutic outcomes while minimizing potential adverse effects. Contraindications include hypersensitivity to proteolytic enzymes and active bleeding disorders. Caution is advised in patients with peptic ulcers or bleeding tendencies. Overall, Xymoheal Forte Tablet offers a targeted enzymatic approach to inflammation management, supporting accelerated recovery and improved functional outcomes in various clinical scenarios.